Efficacy and Safety of Cangrelor in Women Versus Men During Percutaneous Coronary Intervention: Insights From the Cangrelor versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition (CHAMPION PHOENIX) Trial.

Nonetheless, women overall had a higher incidence of bleeding than men regardless of therapy, as has been noted in prior PCI analyses, 24 and a nonsignificant trend was observed across alternate bleeding definitions toward more bleeding in cangrelor-treated women than those treated with clopidogrel.

also in 5,406 other papers